|1.||Panos, Ralph J: 2 articles (01/2013 - 03/2010)|
|2.||Singh, Deepak H: 1 article (06/2012)|
|3.||George, Steven C: 1 article (06/2012)|
|4.||Fraser, Christine: 1 article (06/2012)|
|5.||Moridzadeh, Roxanna: 1 article (06/2012)|
|6.||Gelb, Arthur F: 1 article (06/2012)|
|7.||Freedman, Stephen: 1 article (05/2012)|
|8.||Plint, Amy: 1 article (05/2012)|
|9.||Zemek, Roger: 1 article (05/2012)|
|10.||Black, Karen J L: 1 article (05/2012)|
|1.||Chronic Obstructive Pulmonary Disease (COPD)
01/01/2013 - "A search of the literature in the PubMed database was undertaken using the keywords "COPD," "albuterol," "ipratropium bromide," and "Respimat® Soft Mist Inhaler™"; pertinent references within the identified citations were included. "
03/01/2010 - "At the time of its approval, albuterol/ipratropium bromide was an innovative combination of existing medications for the treatment of COPD. "
08/01/2008 - "The safety and efficacy of Albuterol compared to Albuterol/Ipratropium bromide as rescue medications for COPD patients on maintenance combination therapy of ICS/LABA has not been evaluated. "
08/01/2008 - "A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease."
03/01/2010 - "The recent development and approval of longer acting and more potent beta agonists, anticholinergics and newer combination treatments have surpassed many of the advantages of combined albuterol-ipratropium for the treatment of patients with stable COPD."
|2.||Asthma (Bronchial Asthma)
06/01/2012 - "To measure exhaled NO, postnebulized albuterol/ipratropium spirometry, and Asthma Control Test (ACT) during asthma exacerbation requiring 8- to 10-day tapering oral corticosteroid in nonsmoking patients with moderate-to-severe asthma on moderate-dose inhaled corticosteroid and long-acting β(2)-agonist but not maintenance oral corticosteroid. "
07/01/2002 - "Albuterol, ipratropium, and systemic corticosteroids have been shown to be effective in acute asthma exacerbations. "
08/01/1997 - "A single dose of nebulized Combivent confers additional bronchodilation over salbutamol alone (p < 0.05) in acute asthma. "
08/01/1997 - "This study was carried out to evaluate: (1) whether nebulized ipratropium (0.5 mg) plus salbutamol (2.5 mg) (Combivent) confers additional bronchodilation over nebulized salbutamol (2.5 mg) alone in patients with acute asthma and (2) whether adjustment for prognostic indicators of outcome influences any benefit seen with ipratropium. "
05/01/2012 - "To examine the use of intravenous magnesium in Canadian pediatric emergency departments (EDs) in children requiring hospitalization for acute asthma and association of administration of frequent albuterol/ipratropium and timely corticosteroids with hospitalization. "
|3.||Adrenal Cortex Hormones (Corticosteroids)
|4.||Ipratropium (Ipratropium Bromide)
|9.||Cholinergic Antagonists (Anticholinergics)
|1.||Nebulizers and Vaporizers (Inhaler)